Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2005 Jul;81(957):448–455. doi: 10.1136/pgmj.2004.030577

Functional abdominal pain

P Matthews 1, Q Aziz 1
PMCID: PMC1743310  PMID: 15998821

Abstract

Functional abdominal pain or functional abdominal pain syndrome (FAPS) is an uncommon functional gut disorder characterised by chronic or recurrent abdominal pain attributed to the gut but poorly related to gut function. It is associated with abnormal illness behaviour and patients show psychological morbidity that is often minimised or denied in an attempt to discover an organic cause for symptoms. Thus the conventional biomedical approach to the management of such patients is unhelpful and a person's symptom experience is more usefully investigated using a biopsychosocial evaluation, which necessarily entails a multidisciplinary system of healthcare provision. Currently the pathophysiology of the disorder is poorly understood but is most likely to involve a dysfunction of central pain mechanisms either in terms of attentional bias, for example, hypervigilance or a failure of central pain modulation/inhibition. Although modern neurophysiological investigation of patients is promising and may provide important insights into the pathophysiology of FAPS, current clinical management relies on an effective physician-patient relationship in which limits on clinical investigation are set and achievable treatment goals tailored to the patient's needs are pursued.

Full Text

The Full Text of this article is available as a PDF (189.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Chaer E. D., Feng Y., Willis W. D. A role for the dorsal column in nociceptive visceral input into the thalamus of primates. J Neurophysiol. 1998 Jun;79(6):3143–3150. doi: 10.1152/jn.1998.79.6.3143. [DOI] [PubMed] [Google Scholar]
  2. Aziz Q., Andersson J. L., Valind S., Sundin A., Hamdy S., Jones A. K., Foster E. R., Långström B., Thompson D. G. Identification of human brain loci processing esophageal sensation using positron emission tomography. Gastroenterology. 1997 Jul;113(1):50–59. doi: 10.1016/s0016-5085(97)70079-9. [DOI] [PubMed] [Google Scholar]
  3. Aziz Q., Schnitzler A., Enck P. Functional neuroimaging of visceral sensation. J Clin Neurophysiol. 2000 Nov;17(6):604–612. doi: 10.1097/00004691-200011000-00006. [DOI] [PubMed] [Google Scholar]
  4. Aziz Q., Thompson D. G. Brain-gut axis in health and disease. Gastroenterology. 1998 Mar;114(3):559–578. doi: 10.1016/s0016-5085(98)70540-2. [DOI] [PubMed] [Google Scholar]
  5. Bercík Premysl, Wang Lu, Verdú Elena F., Mao Yukang K., Blennerhassett Patricia, Khan Waliul I., Kean Iain, Tougas Gervais, Collins Stephen M. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology. 2004 Jul;127(1):179–187. doi: 10.1053/j.gastro.2004.04.006. [DOI] [PubMed] [Google Scholar]
  6. Bernstein C. N., Niazi N., Robert M., Mertz H., Kodner A., Munakata J., Naliboff B., Mayer E. A. Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain. 1996 Aug;66(2-3):151–161. doi: 10.1016/0304-3959(96)03062-x. [DOI] [PubMed] [Google Scholar]
  7. Cai Z., McCaslin P. P. Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture. Eur J Pharmacol. 1992 Aug 14;219(1):53–57. doi: 10.1016/0014-2999(92)90579-s. [DOI] [PubMed] [Google Scholar]
  8. Chan C. L. H., Facer P., Davis J. B., Smith G. D., Egerton J., Bountra C., Williams N. S., Anand P. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet. 2003 Feb 1;361(9355):385–391. doi: 10.1016/s0140-6736(03)12392-6. [DOI] [PubMed] [Google Scholar]
  9. Chuang H. H., Prescott E. D., Kong H., Shields S., Jordt S. E., Basbaum A. I., Chao M. V., Julius D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature. 2001 Jun 21;411(6840):957–962. doi: 10.1038/35082088. [DOI] [PubMed] [Google Scholar]
  10. Collins S. M., Piche T., Rampal P. The putative role of inflammation in the irritable bowel syndrome. Gut. 2001 Dec;49(6):743–745. doi: 10.1136/gut.49.6.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Collman P. I., Tremblay L., Diamant N. E. The distribution of spinal and vagal sensory neurons that innervate the esophagus of the cat. Gastroenterology. 1992 Sep;103(3):817–822. doi: 10.1016/0016-5085(92)90012-n. [DOI] [PubMed] [Google Scholar]
  12. Creed Francis, Fernandes Lakshmi, Guthrie Elspeth, Palmer Stephen, Ratcliffe Joy, Read Nicholas, Rigby Christine, Thompson David, Tomenson Barbara, North of England IBS Research Group The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology. 2003 Feb;124(2):303–317. doi: 10.1053/gast.2003.50055. [DOI] [PubMed] [Google Scholar]
  13. Derbyshire Stuart W. G., Whalley Matthew G., Stenger V. Andrew, Oakley David A. Cerebral activation during hypnotically induced and imagined pain. Neuroimage. 2004 Sep;23(1):392–401. doi: 10.1016/j.neuroimage.2004.04.033. [DOI] [PubMed] [Google Scholar]
  14. Drossman D. A., Li Z., Andruzzi E., Temple R. D., Talley N. J., Thompson W. G., Whitehead W. E., Janssens J., Funch-Jensen P., Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 Sep;38(9):1569–1580. doi: 10.1007/BF01303162. [DOI] [PubMed] [Google Scholar]
  15. Drossman D. A. Review article: an integrated approach to the irritable bowel syndrome. Aliment Pharmacol Ther. 1999 May;13 (Suppl 2):3–14. doi: 10.1046/j.1365-2036.1999.0130s2003.x. [DOI] [PubMed] [Google Scholar]
  16. Drossman Douglas A. Functional abdominal pain syndrome. Clin Gastroenterol Hepatol. 2004 May;2(5):353–365. doi: 10.1016/s1542-3565(04)00118-1. [DOI] [PubMed] [Google Scholar]
  17. Drossman Douglas A., Toner Brenda B., Whitehead William E., Diamant Nicholas E., Dalton Chris B., Duncan Susan, Emmott Shelagh, Proffitt Valerie, Akman Donna, Frusciante Karen. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003 Jul;125(1):19–31. doi: 10.1016/s0016-5085(03)00669-3. [DOI] [PubMed] [Google Scholar]
  18. Fu L. W., Longhurst J. C. Interleukin-1beta sensitizes abdominal visceral afferents of cats to ischaemia and histamine. J Physiol. 1999 Nov 15;521(Pt 1):249–260. doi: 10.1111/j.1469-7793.1999.00249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Furlong P. L., Aziz Q., Singh K. D., Thompson D. G., Hobson A., Harding G. F. Cortical localisation of magnetic fields evoked by oesophageal distension. Electroencephalogr Clin Neurophysiol. 1998 Apr;108(3):234–243. doi: 10.1016/s0168-5597(98)00016-1. [DOI] [PubMed] [Google Scholar]
  20. Gonsalkorale W. M., Miller V., Afzal A., Whorwell P. J. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut. 2003 Nov;52(11):1623–1629. doi: 10.1136/gut.52.11.1623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gray D. W., Dixon J. M., Collin J. The closed eyes sign: an aid to diagnosing non-specific abdominal pain. BMJ. 1988 Oct 1;297(6652):837–837. doi: 10.1136/bmj.297.6652.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Guthrie Elspeth, Thompson David. Abdominal pain and functional gastrointestinal disorders. BMJ. 2002 Sep 28;325(7366):701–703. [PMC free article] [PubMed] [Google Scholar]
  23. Gwee K. A., Leong Y. L., Graham C., McKendrick M. W., Collins S. M., Walters S. J., Underwood J. E., Read N. W. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999 Mar;44(3):400–406. doi: 10.1136/gut.44.3.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Harvey R. F., Mauad E. C., Brown A. M. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet. 1987 Apr 25;1(8539):963–965. doi: 10.1016/s0140-6736(87)90304-7. [DOI] [PubMed] [Google Scholar]
  25. Hobday David I., Hobson Anthony R., Sarkar Sanchoy, Furlong Paul L., Thompson David G., Aziz Qasim. Cortical processing of human gut sensation: an evoked potential study. Am J Physiol Gastrointest Liver Physiol. 2002 Aug;283(2):G335–G339. doi: 10.1152/ajpgi.00230.2001. [DOI] [PubMed] [Google Scholar]
  26. Hobson A. R., Aziz Q. Brain imaging and functional gastrointestinal disorders: has it helped our understanding? Gut. 2004 Aug;53(8):1198–1206. doi: 10.1136/gut.2003.035642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Holtmann Gerald, Siffert Winfried, Haag Sebastian, Mueller Norbert, Langkafel Mathias, Senf Wolfgang, Zotz Rainer, Talley Nicholas J. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology. 2004 Apr;126(4):971–979. doi: 10.1053/j.gastro.2004.01.006. [DOI] [PubMed] [Google Scholar]
  28. Holzer P. Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain. Eur J Pharmacol. 2001 Oct 19;429(1-3):177–193. doi: 10.1016/s0014-2999(01)01319-x. [DOI] [PubMed] [Google Scholar]
  29. Huang S. C., Carson R. E., Hoffman E. J., Carson J., MacDonald N., Barrio J. R., Phelps M. E. Quantitative measurement of local cerebral blood flow in humans by positron computed tomography and 15O-water. J Cereb Blood Flow Metab. 1983 Jun;3(2):141–153. doi: 10.1038/jcbfm.1983.21. [DOI] [PubMed] [Google Scholar]
  30. Ji Ru-Rong, Samad Tarek A., Jin Shan-Xue, Schmoll Raymond, Woolf Clifford J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 2002 Sep 26;36(1):57–68. doi: 10.1016/s0896-6273(02)00908-x. [DOI] [PubMed] [Google Scholar]
  31. Kuiken Sjoerd D., Tytgat Guido N. J., Boeckxstaens Guy E. E. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol. 2003 May;1(3):219–228. doi: 10.1053/cgh.2003.50032. [DOI] [PubMed] [Google Scholar]
  32. Lea R., Houghton L. A., Calvert E. L., Larder S., Gonsalkorale W. M., Whelan V., Randles J., Cooper P., Cruickshanks P., Miller V. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2003 Mar 1;17(5):635–642. doi: 10.1046/j.1365-2036.2003.01486.x. [DOI] [PubMed] [Google Scholar]
  33. Mayer E. A., Gebhart G. F. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 1994 Jul;107(1):271–293. doi: 10.1016/0016-5085(94)90086-8. [DOI] [PubMed] [Google Scholar]
  34. Mertz H., Morgan V., Tanner G., Pickens D., Price R., Shyr Y., Kessler R. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000 May;118(5):842–848. doi: 10.1016/s0016-5085(00)70170-3. [DOI] [PubMed] [Google Scholar]
  35. Moriarty K. J., Dawson A. M. Functional abdominal pain: further evidence that whole gut is affected. Br Med J (Clin Res Ed) 1982 Jun 5;284(6330):1670–1672. doi: 10.1136/bmj.284.6330.1670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Naliboff Bruce D., Berman Steve, Chang Lin, Derbyshire Stuart W. G., Suyenobu Brandall, Vogt Brent A., Mandelkern Mark, Mayer Emeran A. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology. 2003 Jun;124(7):1738–1747. doi: 10.1016/s0016-5085(03)00400-1. [DOI] [PubMed] [Google Scholar]
  37. Phillips Mary L., Gregory Lloyd J., Cullen Sarah, Coen Steven, Ng Virginia, Andrew Christopher, Giampietro Vincent, Bullmore Edward, Zelaya Fernando, Amaro Edson. The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. Brain. 2003 Mar;126(Pt 3):669–684. doi: 10.1093/brain/awg065. [DOI] [PubMed] [Google Scholar]
  38. Sarkar S., Hobson A. R., Furlong P. L., Woolf C. J., Thompson D. G., Aziz Q. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol. 2001 Nov;281(5):G1196–G1202. doi: 10.1152/ajpgi.2001.281.5.G1196. [DOI] [PubMed] [Google Scholar]
  39. Sawynok J., Esser M. J., Reid A. R. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci. 2001 Jan;26(1):21–29. [PMC free article] [PubMed] [Google Scholar]
  40. Silverman D. H., Munakata J. A., Ennes H., Mandelkern M. A., Hoh C. K., Mayer E. A. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997 Jan;112(1):64–72. doi: 10.1016/s0016-5085(97)70220-8. [DOI] [PubMed] [Google Scholar]
  41. Spiller R. C., Jenkins D., Thornley J. P., Hebden J. M., Wright T., Skinner M., Neal K. R. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000 Dec;47(6):804–811. doi: 10.1136/gut.47.6.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Svendsen J. H., Munck L. K., Andersen J. R. Irritable bowel syndrome--prognosis and diagnostic safety. A 5-year follow-up study. Scand J Gastroenterol. 1985 May;20(4):415–418. doi: 10.3109/00365528509089673. [DOI] [PubMed] [Google Scholar]
  43. Talley Nicholas J. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol. 2003 Apr;98(4):750–758. doi: 10.1111/j.1572-0241.2003.07306.x. [DOI] [PubMed] [Google Scholar]
  44. Verne G. Nicholas, Himes Nathan C., Robinson Michael E., Gopinath Kaundinya S., Briggs Richard W., Crosson Bruce, Price Donald D. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain. 2003 May;103(1-2):99–110. doi: 10.1016/s0304-3959(02)00416-5. [DOI] [PubMed] [Google Scholar]
  45. Verne G. Nicholas, Price Donald D. Irritable bowel syndrome as a common precipitant of central sensitization. Curr Rheumatol Rep. 2002 Aug;4(4):322–328. doi: 10.1007/s11926-002-0041-x. [DOI] [PubMed] [Google Scholar]
  46. Whitehead W. E., Engel B. T., Schuster M. M. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci. 1980 Jun;25(6):404–413. doi: 10.1007/BF01395503. [DOI] [PubMed] [Google Scholar]
  47. Whitehead William E., Palsson Olafur, Jones Kenneth R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002 Apr;122(4):1140–1156. doi: 10.1053/gast.2002.32392. [DOI] [PubMed] [Google Scholar]
  48. Willert Robert Paul, Woolf Clifford J., Hobson Anthony Robert, Delaney Claire, Thompson David G., Aziz Qasim. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. Gastroenterology. 2004 Mar;126(3):683–692. doi: 10.1053/j.gastro.2003.11.047. [DOI] [PubMed] [Google Scholar]
  49. Willis W. D., Al-Chaer E. D., Quast M. J., Westlund K. N. A visceral pain pathway in the dorsal column of the spinal cord. Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7675–7679. doi: 10.1073/pnas.96.14.7675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Woolf C. J., Salter M. W. Neuronal plasticity: increasing the gain in pain. Science. 2000 Jun 9;288(5472):1765–1769. doi: 10.1126/science.288.5472.1765. [DOI] [PubMed] [Google Scholar]
  51. Woolf C. J., Thompson S. W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991 Mar;44(3):293–299. doi: 10.1016/0304-3959(91)90100-C. [DOI] [PubMed] [Google Scholar]
  52. Yiangou Y., Facer P., Baecker P. A., Ford A. P., Knowles C. H., Chan C. L., Williams N. S., Anand P. ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease. Neurogastroenterol Motil. 2001 Aug;13(4):365–369. doi: 10.1046/j.1365-2982.2001.00276.x. [DOI] [PubMed] [Google Scholar]
  53. Yiangou Y., Facer P., Dyer N. H., Chan C. L., Knowles C., Williams N. S., Anand P. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet. 2001 Apr 28;357(9265):1338–1339. doi: 10.1016/s0140-6736(00)04503-7. [DOI] [PubMed] [Google Scholar]
  54. Yiangou Y., Facer P., Smith J. A., Sangameswaran L., Eglen R., Birch R., Knowles C., Williams N., Anand P. Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur J Gastroenterol Hepatol. 2001 Aug;13(8):891–896. doi: 10.1097/00042737-200108000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES